InnoCan Pharma Corporation (IP40)
Market Closed
20 Aug, 20:00
XSTU XSTU Primary €
1. 35
+0
+0.3704%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
€ 1.35
Previous Close Want to track IP40 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InnoCan Pharma Corporation (IP40) Statistics
Valuation metrics
Market Cap -
Enterprise value -
Trailing P/E (ttm) -9.04
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 4.5M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.64K
Average volume (90 days) 1.58K
Price summary
52-Week low 0.12
52-Week high 9.1
Beta -
50-Day moving average 6.57
200-Day moving average 6.39
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:65
Last split Date 5 Sep 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.9%
Operating margin 0%
Operational effectiveness
Return on assets -0.11%
Return on equity -0.14%
Income Statement
Revenue (ttm) 26.61M
Revenue per share (ttm) 5.94
Quarterly revenue growth (yoy) -0.27%
Gross profit (ttm) 23.93M
EBITDA -
Net income to common (ttm) -1.12M
Diluted EPS (ttm) -0.25
Quarterly earnings growth (yoy) -0.08%
Balance Sheet
Total cash (mrq) 6.69M
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 7.7%
Book value per share (mrq) -
Cash Flow
Cash flow statement 2.9M
Levered free cash flow (LFCF) -1.12M
